FEI.org
21 Jun 2016
The FEI has announced an adverse analytical finding involving prohibited substances.
Samples taken at the 80km CEI*1 in Amman (JOR) on 21 May 2016 from the second-placed horse Obama Al Aswad (FEI ID 104DF50, ridden by Nayef Al Fayez (FEI ID 10066952), have returned positive for the banned substance Boldenone, and the controlled medications Dexamethasone, Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone.
Boldenone, an anabolic steroid, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
The corticosteroid Dexamethasone is used to treat inflammatory and auto-immune conditions, while the non-steroidal anti-inflammatory drugs Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone are used for pain relief.
The athlete has been provisionally suspended from the date of notification (20 June 2016). The horse has also been provisionally suspended for a two-month period.
Further details on this case can be found here.
FEI Goes Quiet on Sanctions Against Countries with a Doping Problem
HorseSport.com - Full Article After a huge spike in positives in Saudi Arabia, last year the FEI told HorseSport.com it would discuss a co...
-
Inside.fei.org 17 December 2020 The FEI Board took a series of key decisions on allocation, cancellation, and reopening of bids for FEI C...
-
WAM.ae 02/09/2023 CASTELSAGRAT, France, 2nd September, 2023 (WAM) – The UAE Saturday won the FEI Endurance World Championship for Young R...
-
StandleeForage.com - Beyond the Barn Podcast - Listen New Beyond the Barn Podcast Episode Episode 67: The Longest & Toughest Horse R...